High glucose induced c-Met activation promotes aggressive phenotype and regulates expression of glucose metabolism genes in HCC cells
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
High glucose induced c-Met activation promotes aggressive phenotype and regulates expression of glucose metabolism genes in HCC cells. / Topel, Hande; Bağırsakçı, Ezgi; Yılmaz, Yeliz; Güneş, Ayşim; Bağcı, Gülsün; Çömez, Dehan; Kahraman, Erkan; Korhan, Peyda; Atabey, Neşe.
In: Scientific Reports, Vol. 11, 11376, 2021.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - High glucose induced c-Met activation promotes aggressive phenotype and regulates expression of glucose metabolism genes in HCC cells
AU - Topel, Hande
AU - Bağırsakçı, Ezgi
AU - Yılmaz, Yeliz
AU - Güneş, Ayşim
AU - Bağcı, Gülsün
AU - Çömez, Dehan
AU - Kahraman, Erkan
AU - Korhan, Peyda
AU - Atabey, Neşe
PY - 2021
Y1 - 2021
N2 - Hepatocellular carcinoma (HCC) is strongly associated with metabolic dysregulations/deregulations and hyperglycemia is a common metabolic disturbance in metabolic diseases. Hyperglycemia is defined to promote epithelial to mesenchymal transition (EMT) of cancer cells in various cancers but its molecular contribution to HCC progression and aggressiveness is relatively unclear. In this study, we analyzed the molecular mechanisms behind the hyperglycemia-induced EMT in HCC cell lines. Here, we report that high glucose promotes EMT through activating c-Met receptor tyrosine kinase via promoting its ligand-independent homodimerization. c-Met activation is critical for high glucose induced acquisition of mesenchymal phenotype, survival under high glucose stress and reprogramming of cellular metabolism by modulating glucose metabolism gene expression to promote aggressiveness in HCC cells. The crucial role of c-Met in high glucose induced EMT and aggressiveness may be the potential link between metabolic syndrome-related hepatocarcinogenesis and/or HCC progression. Considering c-Met inhibition in hyperglycemic patients would be an important complementary strategy for therapy that favors sensitization of HCC cells to therapeutics.
AB - Hepatocellular carcinoma (HCC) is strongly associated with metabolic dysregulations/deregulations and hyperglycemia is a common metabolic disturbance in metabolic diseases. Hyperglycemia is defined to promote epithelial to mesenchymal transition (EMT) of cancer cells in various cancers but its molecular contribution to HCC progression and aggressiveness is relatively unclear. In this study, we analyzed the molecular mechanisms behind the hyperglycemia-induced EMT in HCC cell lines. Here, we report that high glucose promotes EMT through activating c-Met receptor tyrosine kinase via promoting its ligand-independent homodimerization. c-Met activation is critical for high glucose induced acquisition of mesenchymal phenotype, survival under high glucose stress and reprogramming of cellular metabolism by modulating glucose metabolism gene expression to promote aggressiveness in HCC cells. The crucial role of c-Met in high glucose induced EMT and aggressiveness may be the potential link between metabolic syndrome-related hepatocarcinogenesis and/or HCC progression. Considering c-Met inhibition in hyperglycemic patients would be an important complementary strategy for therapy that favors sensitization of HCC cells to therapeutics.
KW - Carcinoma, Hepatocellular/genetics
KW - Cell Line, Tumor
KW - Cell Movement/drug effects
KW - Dimerization
KW - Epithelial-Mesenchymal Transition
KW - Gene Expression Regulation, Neoplastic
KW - Glucose/administration & dosage
KW - Glycolysis
KW - Humans
KW - Liver Neoplasms/genetics
KW - Neoplasm Invasiveness
KW - Receptor Protein-Tyrosine Kinases/metabolism
KW - Signal Transduction/drug effects
U2 - 10.1038/s41598-021-89765-5
DO - 10.1038/s41598-021-89765-5
M3 - Journal article
C2 - 34059694
VL - 11
JO - Scientific Reports
JF - Scientific Reports
SN - 2045-2322
M1 - 11376
ER -
ID: 389913404